Skip to main content

September 2017 Amendment

DateResponseResponse
Oct 17th 2017 1:48 pm Response: #311773 Attached please find the comments of Sunovion in response to the Massachusetts Section 1115 Waiver Demonstration Amendment Request.
Oct 17th 2017 4:32 pm Response: #311777 Please find the response from the Massachusetts Pharmacists Association attached.
Oct 17th 2017 8:36 pm Response: #311781 The AIDS Institute, a national, non-partisan, non-profit organization dedicated to supporting and protecting health care access for people living with HIV/AIDS, hepatitis, and other chronic and serious health conditions, is pleased to submit comments on the Commonwealth of Massachusetts request to amend its Section 1115 Medicaid Waiver for MassHealth (11-W-00030/1). We are extremely concerned that if the Centers for Medicare and Medicaid Services (CMS) approves aspects of this Waiver Request, MassHealth beneficiaries living with HIV, hepatitis, and other serious and chronic conditions will not have access to the life-saving and curative medications their providers prescribe to keep them healthy and alive. While we truly understand the need to control costs in the Medicaid program, limiting beneficiaries’ access to needed medications is not the answer. Massachusetts has at its disposal other means to reduce prescription drugs costs. We encourage the Commonwealth to pursue these other mechanisms rather than take drastic steps that, if approved, would run contrary to current law and undermine the Medicaid program not only for Massachusetts, but potentially throughout the country, as well.
Oct 18th 2017 8:20 am Response: #311785 Please see the attached comments on behalf of Planned Parenthood League of Massachusetts
Oct 18th 2017 3:13 pm Response: #311805 Please find attached a letter from 222 patient and provider groups regarding the MA 1115 waiver. If you have additional questions, please feel free to reach out to Keysha Brooks-Coley with the American Cancer Society Cancer Action Network (ACS CAN) at keysha.brooks-coley@cancer.org.
Oct 19th 2017 10:13 am Response: #311813 UCB appreciates the opportunity to provide comments on the Massachusetts MassHealth §1115 Demonstration Waiver Request (“MassHealth Waiver Request”) to impose significant limitations on Medicaid patients’ access to prescription drugs. For the reasons described in the attached comment letter, UCB is concerned about the negative impact that the MassHealth Waiver Request will have on patients living with severe chronic disease, and therefore we strongly recommend that CMS deny this request. Should you have any questions or comments, please contact me at Alison.Anway@UCB.com or 404-295-0751.
Oct 19th 2017 12:02 pm Response: #311825 Comments submitted by the National Immigration Law Center on October 19, 2017, are attached below.
Oct 19th 2017 2:27 pm Response: #311829 Please accept the following comment on behalf of Parent Project Muscular Dystrophy.
Oct 19th 2017 3:31 pm Response: #311833 Please see attached AstraZeneca's comments to the MassHealth amendment request.
Oct 19th 2017 4:20 pm Response: #311841 Please find attached comments submitted on behalf of the American Medical Association.
First pagePrevious page Page
of 5 Next pageLast page